x

Posted 13 February, 2023

USANA HEALTH SCIENCES INC appointed Jim Brown as new CEO

NYSE:USNA appointed new Chief Executive Officer Jim Brown in a 8-K filed on 13 February, 2023.


  On February 13, 2023, USANA Health Sciences, Inc. (the "Company" or "USANA") announced that its Board of Directors (the "Board") has appointed Jim Brown as the Company's Chief Executive Officer effective July 1, 2023 (the "Effective Date").  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of USANA HEALTH SCIENCES INC
Health Care/Life Sciences • Pharmaceuticals
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.
Market Cap
$588M
View Company Details
USANA HEALTH SCIENCES INC by TradingView
Relevant filing section
Item 5.02 
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On February 13, 2023, USANA Health Sciences, Inc. (the "Company" or "USANA") announced that its Board of Directors (the "Board") has appointed Jim Brown as the Company's Chief Executive Officer effective July 1, 2023 (the "Effective Date"). Mr. Brown will succeed Kevin Guest, who will transition to Executive Chairman of the Company on the Effective Date.


Mr. Brown has served as President of the Company since October 2019. Prior to that he served as President and Chief Operating Officer from November 2016 to October 2019, and Chief Operating Officer from November 2013 until November 2016. Mr. Brown served in various other management positions at the Company prior to 2013.


Mr. Brown's current compensation will remain unchanged until the Effective Date. Prior to the Effective Date, the Compensation Committee of the Board will set Mr. Brown's new compensation as Chief Executive Officer. There is no arrangement or understanding between Mr. Brown and any other persons pursuant to which Mr. Brown was selected as Chief Executive Officer. There are no family relationships between Mr. Brown and any director or executive officer of the Company and there are no relationships between Mr. Brown and the Company or any of its subsidiaries that would require disclosure pursuant to Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.


Mr. Guest has served as Chairman of the Board and Chief Executive Officer since May 2020. Prior to that he served as Chief Executive Officer from November 2016 to May 2020, and as Co-Chief Executive Officer from August 2015 to November 2016. Mr. Guest served as President of the Company from August 2014 to August 2015 and in various other management positions at the Company prior to 2014.


Mr. Guest's current compensation will remain unchanged until the Effective Date. Prior to the Effective Date, the Compensation Committee of the Board will set Mr. Guest's new compensation as Executive Chairman. There is no arrangement or understanding between Mr. Guest and any other persons pursuant to which Mr. Guest was selected as Executive Chairman. There are no family relationships between Mr. Guest and any director or executive officer of the Company and there are no relationships between Mr. Guest and the Company or any of its subsidiaries that would require disclosure pursuant to Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended.